Complement activation associated with polysorbate 80 in beagle dogs

International Immunopharmacology

Volumn 15, Issue 1, 2013, Pages 144-149

  Liu, Zhaoping ^a   Qiu, Shidong ^a,b   Liu, Zhaohua ^a   Hou, Li ^b   Li, Yuanyuan ^a   Wang, Jiao ^a   Wang, Hong ^a   Du, Wu ^a   Wang, Wenfang ^a   Qin, Yizhuo ^a  

^a SHANDONG UNIVERSITY   (China)

^b Shandong Quality Inspection Center for Medical Devices   (China)

Author keywords

Canine model; Cardiopulmonary distress; Complement activation related pseudoallergy; Non immune anaphylaxis; Polysorbate 80

Indexed keywords

COMPLEMENT COMPONENT C4D; EGTAZIC ACID; HISTAMINE; IMMUNOGLOBULIN E; MAGNESIUM ION; POLYSORBATE 80;

ANAPHYLAXIS; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DOG; DRUG EFFECT; ELECTROCARDIOGRAM; FEMALE; HISTAMINE RELEASE; IN VITRO STUDY; IN VIVO STUDY; LUNG CIRCULATION; LUNG PRESSURE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC CIRCULATION;

ANIMALS; BLOOD PRESSURE; COMPLEMENT ACTIVATION; DOGS; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HISTAMINE RELEASE; INJECTIONS, INTRAVENOUS; POLYSORBATES; SURFACE-ACTIVE AGENTS;

EID: 84872309685     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.10.021     Document Type: Article

References (35)

1. Z. Weiszhár, J. Czúcz, C. Révész, L. Rosivall, J. Szebeni, and Z. Rozsnyay Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20 Eur J Pharm Sci 45 4 2011 492 498
2. E.A. Coors, H. Seybold, H.F. Merk, and V. Mahler Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions Ann Allergy Asthma Immunol 95 2005 593 599
3. I. Badiu, M. Geuna, E. Heffler, and G. Rolla Hypersensitivity reaction to human papillomavirus vaccine due to polysorbate 80 BMJ Case Reports 2012 http://dx.doi.org/10.1136/bcr.02.2012.5797
4. A.J. ten Tije, J. Verweij, W.J. Loos, and A. Sparreboom Pharmacological effects of formulation vehicles: implications for cancer chemotherapy Clin Pharmacokinet 42 2003 665 685
5. A.H. Liang, C.Y. Li, C.Y. Cao, R. Hao, Y. Yi, and J. Guo Animal models and methodologies for evaluation of Chinese herbal injection-induced anaphylactoid reactions Mode Tradit Chin Med Mater Med 12 6 2010 998 1004
6. W.W. Sun, Y.K. Li, J.Y. Zhang, M.Y. Zhang, P. He, and W. Hao Anaphylactoid reactions inducing effect of polysorbate 80 and polysorbate 80 contained Houttuynia cordata injection on beagle Chin J Integr Med 31 01 2011 90 93
7. J. Luiting, J.G. de Monchy, T.J. Hiltermann, and J.N. Oude Elberink Desensitisation to circumvent hypersensitivity reactions; treatment with docetaxel still possible Ned Tijdschr Geneeskd 155 2011 A2980
8. W.J. Slichenmyer, and D.D. Von Hoff Taxol: a new and effective anti-cancer drug Anticancer Drugs 2 1991 519 530
9. K.S. Price, and R.G. Hamilton Anaphylactoid reactions in two patients after omalizumab administration after successful long-term therapy Allergy Asthma Proc 28 2007 313 319
10. A. Eschalier, J. Lavarenne, C. Burtin, M. Renoux, E. Chapuy, and M. Rodriguez Study of histamine release induced by acute administration of antitumor agents in dogs Cancer Chemother Pharmacol 21 1988 246 250
11. G.K. Ogilvie, C.A. Cockburn, W.J. Tranquilli, R.W. Reschke, and R.M. Weigel Hypotension and cutaneous reactions associated with intravenous administration of etoposide in the dog Am J Vet Res 49 1988 1367 1370
12. J. Ring, H. Behrendt, and A. de Weck History and classification of anaphylaxis Chem Immunol Allergy 95 2010 1 11
13. J.K. Lee, and P. Vadas Anaphylaxis: mechanisms and management Clin Exp Allergy 41 2011 923 938
14. FDA Guidance for industry immunotoxicology evaluation of investigational new drugs 2002 [14]
15. J. Szebeni Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity Toxicology 216 2005 106 121
16. J. Descotes, C. Payen, and T. Vial Pseudo-allergic drug reactions with special reference to direct histamine release Perspect Exp Clin Immunotoxicol 1 2004 27 36
17. M. Toman, J. Krejci, K. Pinka, and P. Mensik Causes of anaphylactoid reactions in cattle after administration of lipoid preparations Vet Med (Praha) 37 1992 417 426
18. O.M. Merkel, R. Urbanics, P. Bedocs, Z. Rozsnyay, L. Rosivall, and M. Toth In vitro and in vivo complement activation and related anaphylactic effects associated with polyethylenimine and polyethylenimine-graft-poly(ethylene glycol) block copolymers Biomaterials 32 2011 4936 4942
19. J. Szebeni, F.M. Muggia, and C.R. Alving Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study J Natl Cancer 90 1998 300 306
20. J. Szebeni, L. Baranyi, S. Savay, J. Milosevits, M. Bodo, and R. Bunger The interaction of liposomes with the complement system: in vitro and in vivo assays Methods Enzymol 373 2003 136 154
21. G.M. Vercellotti, D.E. Hammerschmidt, P.R. Craddock, and H.S. Jacob Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroids prophylaxis Blood 59 1982 1299 1304
22. J. Szebeni, J.L. Fontana, N.M. Wassef, P.D. Mongan, D.S. Morse, and D.E. Dobbins Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody Circulation 99 1999 2302 2309
23. D. Ricklin, G. Hajishengallis, K. Yang, and J.D. Lambris Complement: a key system for immune surveillance and homeostasis Nat Immunol 11 2010 785 797
24. S.M. Moghimi, A.C. Hunter, C.M. Dadswell, S. Savay, C.R. Alving, and J. Szebeni Causative factors behind poloxamer 188 (Pluronic F68, Flocor™)-induced complement activation in human sera: a protective role against poloxamer-mediated complement activation by elevated serum lipoprotein levels Biochim Biophys Acta 1689 2004 103 113
25. S.M. Moghimi, A.J. Andersen, D. Ahmadvand, P.P. Wibroe, T.L. Andresen, and A.C. Hunter Material properties in complement activation Adv Drug Deliv Rev 63 2011 1000 1007
26. S.M. Moghimi, A.J. Andersen, S.H. Hashemi, B. Lettiero, D. Ahmadvand, and A.C. Hunter Complement activation cascade triggered by PEG-PL engineered nanomedicines and carbon nanotubes: the challenges ahead J Control Release 146 2010 175 181
27. J. Szebeni, C.R. Alving, L. Rosivall, R. Bunger, L. Baranyi, and P. Bedocs Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles J Liposome Res 17 2007 107 117
28. L. Sun, X.M. Liu, X. Wang, W.H. Qi, L.Z. Shen, and B. Li Preliminary exploration of Tween-80 causes animals pseudoallergic reactions J Toxicol 21 2007 322
29. Y.M. Li, X.F. Pu, L. Lei, D.B. Zhang, L. Zhang, and H.Y. Peng Experimental study on adverse reaction by Intravenous Yuxingcao injection II. Allergy research for guinea pigs Clin Chin Mater Clin Med 24 2008 63
30. W.W. Sun, Y.K. Li, J.Y. Zhang, M.Y. Zhang, W. Hao, and L. Zhao Experimental Study on Macaca fascicularis anaphylactoid reactions induced by Houttuynia cordata injection Chin J Integr Med 31 2011 90 93
31. M.Y. Zhang, L.D. Li, Y.K. Li, J.Y. Zhang, P. He, and W.W. Sun Experimental study on anaphylactoid reactions of Houttuynia cordata injections in rhesus macaque Pharmacol Clin Chin Mater Med 2009 55 57
32. I. Hamad, A.C. Hunter, J. Szebeni, and S.M. Moghimi Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process Mol Immunol 46 2008 225 232
33. A. Christiansen, T. Backensfeld, K. Denner, and W. Weitschies Effects of non-ionic surfactants on cytochrome P450-mediated metabolism in vitro Eur J Pharm Biopharm 78 2011 166 172
34. E. Friche, P.B. Jensen, M. Sehested, E.J. Demant, and N.N. Nissen The solvents Cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor Cancer Commun 2 1990 297 303
35. T.E. Mollnes Early- and late-phase activation of complement evaluated by plasma levels of C3d, g and the terminal complement complex Complement 2 1985 156 164